第一医药(600833) - 2017 Q1 - 季度财报

Financial Performance - Net profit attributable to shareholders increased by 6.00% to CNY 14,026,908.93 year-on-year[6] - Operating revenue for the period was CNY 433,995,161.69, a slight increase of 0.86% compared to the same period last year[6] - Basic earnings per share increased by 6.07% to CNY 0.0629[6] - Operating profit rose to ¥18,318,932.64, reflecting an increase of 7.9% compared to ¥16,983,715.38 in the previous period[19] - Net profit for the current period reached ¥14,026,908.93, up 6% from ¥13,233,492.76 year-over-year[19] - Total comprehensive income for the current period is ¥45,553,130.07, compared to a loss of ¥64,583,843.99 in the previous period[19] Assets and Liabilities - Total assets increased by 5.77% to CNY 1,253,624,515.18 compared to the end of the previous year[6] - Total assets increased to ¥1,253,624,515.18 from ¥1,185,287,123.94, representing a growth of approximately 5.8%[13] - Current assets rose to ¥697,859,337.18, up from ¥669,837,559.84, indicating an increase of about 4.5%[13] - Total liabilities increased to ¥472,075,274.78 from ¥449,291,013.61, which is an increase of approximately 5.1%[14] - Current liabilities totaled ¥365,328,220.17, up from ¥352,957,941.20, indicating a rise of about 3.5%[14] - Non-current liabilities rose to ¥106,747,054.61 from ¥96,333,072.41, reflecting an increase of approximately 10.4%[14] - Shareholders' equity increased to ¥781,549,240.40 from ¥735,996,110.33, representing a growth of about 6.2%[14] Cash Flow - The net cash flow from operating activities was CNY 22,346,771.89, representing an increase of 8.22% year-on-year[6] - Total cash inflow from operating activities for Q1 2017 was CNY 490,501,133.42, a decrease of 3.0% compared to CNY 509,024,942.61 in Q1 2016[22] - Cash and cash equivalents at the end of the period reached CNY 249,716,567.70, an increase of 13.8% from CNY 219,327,360.32 at the end of Q1 2016[22] - Net cash flow from operating activities for the parent company was CNY 14,625,861.96, an increase of 7.5% from CNY 13,603,624.78 in Q1 2016[24] - The net increase in cash and cash equivalents for the parent company was CNY 19,388,703.68, an increase of 50.5% compared to CNY 12,931,341.81 in the same period last year[24] Receivables and Inventory - Accounts receivable increased by 42.68% to CNY 179,759,641.65, indicating a significant rise in outstanding payments[9] - Prepayments surged by 363.55% to CNY 11,189,247.25, primarily due to unpaid invoices for goods[9] - Other current assets decreased by 61.03% to CNY 5,711,318.34, mainly due to a reduction in unclaimed VAT[9] - Inventory decreased to ¥248,028,375.73 from ¥296,355,701.07, showing a decline of about 16.3%[13] Shareholder Information - The number of shareholders reached 27,665 by the end of the reporting period[8]